Zymeworks

Performance

About Zymeworks

Zymeworks is a biopharmaceutical company focused on developing novel medicines for patients with difficult-to-treat cancers and other serious diseases. The company operates an integrated in-house R&D engine built around proprietary platforms for antibody-drug conjugates and multispecific antibody therapeutics, pursuing collaborations to bring therapies globally. It positions itself as a royalty-driven organization differentiated by its internal discovery and development capabilities and partnerships.